Intco Medical Technology Co., Ltd. (SHE:300677)
24.70
+0.81 (3.39%)
Apr 1, 2025, 2:45 PM CST
Intco Medical Technology Revenue
Intco Medical Technology had revenue of 2.59B CNY in the quarter ending September 30, 2024, with 48.04% growth. This brings the company's revenue in the last twelve months to 8.98B, up 39.29% year-over-year. In the year 2023, Intco Medical Technology had annual revenue of 6.92B with 4.61% growth.
Revenue (ttm)
8.98B
Revenue Growth
+39.29%
P/S Ratio
1.74
Revenue / Employee
820.47K
Employees
10,939
Market Cap
15.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.92B | 304.91M | 4.61% |
Jan 1, 2023 | 6.61B | -9.63B | -59.27% |
Jan 1, 2022 | 16.24B | 2.40B | 17.37% |
Dec 31, 2020 | 13.84B | 11.75B | 564.29% |
Dec 31, 2019 | 2.08B | 190.40M | 10.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |